Results 161 to 170 of about 1,025,133 (312)

Comments on Kostek et al.: Deciding on Fine Needle Aspiration Biopsy in Thyroid Incidentalomas in FDG-PET/CT: Should Ultrasonographic Evaluation or FDG Uptake Be in the Foreground? [PDF]

Sisli Etfal Hastan Tip Bul
Vatankulu B, Sager S.
europepmc   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

Dynamic Predictors for Malignancy Risk of Follicular Thyroid Neoplasms: A Real-World, 10-Year Cohort Study. [PDF]

Cancer Med
Shan R, Li X, Zhang F, Fu P, Mei F, Song SB, Sun BK, Chen J, Yang Y, Yang YH, Liu JY, Hu RZ, Yang WY, Yuan CH, Liu Z.   +14 more
europepmc   +1 more source

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

The “Discovery” of Markers to be Tested as Immune Complexes: The Role Played by the Systematic Review of the Literature

The International Journal of Biological Markers, 2009
Sabrina Meo, Roberta Franceschini, Chiara Trevisiol, Elisa Squarcina, Massimo Gion   +4 more
doaj   +1 more source

Assessing the accuracy of thyroid nodule risk-stratification tools in Hispanic and non-Hispanic patients. [PDF]

J Endocr Soc
Tamamian C, He CJ, Choe C, Guo T.
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Comment on suspicious for malignancy cytology: nuclear characteristics deserve special attention in reported cytology analysis - real-world scenario cohort in thyroidology. [PDF]

Arch Endocrinol Metab
Sengul I, Sengul D.
europepmc   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Adequacy Criteria for Thyroid Fine-Needle Aspiration in the Era of the Bethesda Reporting System. [PDF]

Yonsei Med J
Kwak JY, Cho S, Lee HS, Yoon JH, Ali SZ, Hong SW.   +5 more
europepmc   +1 more source